Grifols (GRFS) Non-cash Items (2010 - 2020)
Grifols' (GRFS) quarterly Non-cash Items came in at -$66.3 million in Q1 2020, down 90.98% YoY from -$735.3 million in Q2 2019, and down 226.55% on a QoQ basis from $52.4 million in Q4 2019.
Grifols (GRFS) Non-cash Items (2010 - 2020) Analysis & Trends
Grifols (GRFS) has 11 years of Non-cash Items data on file, last reported at -$66.3 million in Q1 2020.
- Quarterly Non-cash Items fell 90.98% year-over-year to -$66.3 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was -$50.8 million (down 126.44% YoY) and the FY2025 annual result came in at $1.3 billion, up 5.8% from the prior year.
- Non-cash Items eased to -$66.3 million in Q1 2020, from $52.4 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $297.0 million in Q2 2017 to a low of -$314.7 million in Q4 2016.
- A 5-year average of $28.0 million and a median of $11.9 million in 2018 frame the typical range for Non-cash Items.
- The widest YoY moves for Non-cash Items: up 2571.89% in 2019, down 391.37% in 2019.
- Tracing GRFS's Non-cash Items over 5 years: stood at -$314.7 million in 2016, then jumped by 122.67% to $71.3 million in 2017, then slumped by 102.97% to -$2.1 million in 2018, then soared by 2571.89% to $52.4 million in 2019, then sank by 226.55% to -$66.3 million in 2020.
- The last three Non-cash Items figures came in at -$66.3 million (Q1 2020), $52.4 million (Q4 2019), and -$34.7 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -66.31 Mn |
| Mar 31, 2020 | -66.31 Mn |
| Dec 31, 2019 | 52.39 Mn |
| Dec 31, 2019 | 52.39 Mn |
| Mar 31, 2019 | -34.72 Mn |
| Mar 31, 2019 | -34.72 Mn |
| Dec 31, 2018 | -2.12 Mn |
| Dec 31, 2018 | -2.12 Mn |
| Jun 30, 2018 | 216.86 Mn |
| Jun 30, 2018 | 216.86 Mn |
| Mar 31, 2018 | 11.92 Mn |
| Mar 31, 2018 | 11.92 Mn |
| Dec 31, 2017 | 71.33 Mn |
| Dec 31, 2017 | 71.33 Mn |
| Jun 30, 2017 | 297.02 Mn |
| Jun 30, 2017 | 297.02 Mn |
| Mar 31, 2017 | -22.48 Mn |
| Mar 31, 2017 | -22.48 Mn |
| Dec 31, 2016 | -314.69 Mn |
| Dec 31, 2016 | -314.69 Mn |